BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 3028378)

  • 1. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
    Ransjö M; Lerner UH
    Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin sensitizes parathyroid hormone-induced cyclic AMP response, but not the bone resorptive effect, in mouse calvarial bones.
    Lerner UH; Ransjö M; Sahlberg K; Ljunggren O; Fredholm BB
    Bone Miner; 1989 Jan; 5(2):169-81. PubMed ID: 2537671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
    Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
    J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
    Lerner UH; Ransjö M; Ljunggren O
    Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
    Lerner UH; Larsson A
    Bone; 1987; 8(3):179-89. PubMed ID: 2955802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M; Fredholm BB; Lerner UH
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U; Ransjö M; Fredholm BB
    Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bone resorption in vitro by serine-esterase inhibitors.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Feb; 964(2):129-36. PubMed ID: 3342254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH
    J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of adenosine receptors in bone. Studies on the effect of adenosine analogues on cyclic AMP formation and bone resorption in cultured mouse calvaria.
    Lerner UH; Sahlberg K; Fredholm BB
    Acta Physiol Scand; 1987 Oct; 131(2):287-96. PubMed ID: 2823534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro.
    Lerner UH; Ransjö M; Klaushofer K; Hörandner H; Hoffmann O; Czerwenka E; Koller K; Peterlik M
    Bone; 1989; 10(5):377-87. PubMed ID: 2605053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of forskolin on bone in organ culture.
    Krieger NS; Stern PH
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E44-8. PubMed ID: 3028149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different roles for calcium and cyclic AMP in the action of PTH: studies in bone explants and isolated bone cells.
    Herrmann-Erlee MP; van der Meer JM; Löwik CW; van Leeuwen JP; Boonekamp PM
    Bone; 1988; 9(2):93-100. PubMed ID: 2841959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy.
    Lerner UH; Grubb A
    J Bone Miner Res; 1992 Apr; 7(4):433-40. PubMed ID: 1319105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenylate cyclase blockers dissociate PTH-stimulated bone resorption from cAMP production.
    Reid IR; Lowe C; Cornish J; Gray DH; Skinner SJ
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E708-14. PubMed ID: 1692185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation and bone metabolism: some characteristics of the bone resorptive effect of thrombin in mouse calvarial bones in vitro.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Mar; 964(3):309-18. PubMed ID: 3126818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.
    Conaway HH; Grigorie D; Lerner UH
    J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine has the capacity to stimulate calcium release in organ culture of neonatal mouse calvaria.
    Lerner UH; Mellström D
    Calcif Tissue Int; 1992 Dec; 51(6):424-8. PubMed ID: 1451009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of bone resorption and cell proliferation in vitro by human gingival fibroblasts from patients with periodontal disease.
    Lerner UH; Hänström L; Sjöström S
    Bone Miner; 1990 Sep; 10(3):225-42. PubMed ID: 2224207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.